Search Results - S. M. Radaev
- Showing 1 - 2 results of 2
-
1
Mononuclear cells from human umbilical cord/placental blood: Assessment of allergenicity and impact on immune status in experimental warm-blooded animals by S. V. Skupnevskiy, R. V. Saveljev, E. G. Pukhaeva, Ya. V. Morozova, S. M. Radaev, V. A. Smirnov, A. A. Grin
Published 2025-03-01Human mononuclear cells from umbilical cord blood (HUCBMCs) are used as the main or adjuvant therapy for treatment of about 80 different diseases, due to high proliferative activity of these cells, low immunogenicity and an opportunity of selecting rare HLA types for transplants. In this regard, ass...
Get full text
Article -
2
Cell therapy for spinal cord contusion injury: evaluation of the efficacy of cryopreserved human umbilical cord blood mononuclear cells in a preclinical model by S.I. Ryabov, M.A. Zvyagintseva, S.A. Bazanovich, Y.V. Morozova, S.M. Radaev, S.Е. Zuev, M.A. Khvostova, V.A. Karanadze, A.A. Grin, V.A. Smirnov
Published 2024-12-01Objective. To evaluate the effect of systemic application of cryopreserved human umbilical cord blood mononuclear cells (hUCB-MNCs) in the acute period of spinal cord contusion injury (SCI) on the volume of zone of the spinal cord damage using high-field MRI. Material and Methods. This study was p...
Get full text
Article